What tests should I have for Nhl Dlbcl

Testing for Diffuse Large B-Cell Lymphoma (DLBCL)

Great question! Let me explain what tests are typically recommended for DLBCL diagnosis and treatment planning. According to NCCN Guidelines for Patients: Diffuse Large B-Cell Lymphomas, here's what doctors generally evaluate:

Initial Diagnostic Tests

Tissue Diagnosis:

• Lymph node biopsy — A small sample of lymph node tissue is removed (using a needle or minor surgery) to confirm DLBCL and identify the specific subtype
• Pathology review — A specialist examines the tissue under a microscope to look for abnormal B-cells

Immunophenotyping (identifying cell markers):

• Uses antibodies to detect specific proteins on cancer cells
• Helps distinguish DLBCL from other lymphomas
• Can be done using flow cytometry (a lab technique that analyzes cells) or immunohistochemistry (staining tissue samples)

Genetic/Biomarker Testing:

• FISH testing — Looks for rearrangements in genes like MYC, BCL2, and BCL6
• Karyotype — Examines chromosomes for abnormalities
• Mutation testing — Identifies specific genetic changes that might guide treatment
• EBER-ISH — Tests for Epstein-Barr virus in the lymphoma cells
• Beta-2-microglobulin (B2M) — A protein marker that helps predict prognosis

---

Staging & Treatment Planning Tests

Blood Tests:

• Complete blood count (CBC) with differential
• Lactate dehydrogenase (LDH) — elevated levels suggest more aggressive disease
• Comprehensive metabolic panel (CMP)
• Uric acid level
• Hepatitis B testing
• HIV testing (in some cases)

Imaging:

• PET/CT scan (preferred) or CT scan with contrast of chest, abdomen, and pelvis — Shows where lymphoma is located in your body
• Head or neck imaging — May be done if needed based on your symptoms

Physical Exam:

• Special attention to lymph nodes and checking liver/spleen size
• Performance status — Assessment of how well you're functioning

Other Tests:

• International Prognostic Index (IPI) — A scoring system that predicts how the lymphoma will respond to treatment
• Pregnancy test — If chemotherapy or radiation is planned
• Heart function tests — Some treatments can affect the heart
• Bone marrow biopsy — May be done in certain cases to check for lymphoma involvement

Possible Additional Tests:

• Lumbar puncture — Checks spinal fluid for lymphoma cells if there's risk of CNS (brain/spinal cord) involvement

---

Why These Tests Matter

According to the NCCN Guidelines, these tests help your doctors:

• Confirm the diagnosis and identify the DLBCL subtype (GCB vs. non-GCB)
• Determine the stage (how far the cancer has spread)
• Assess prognosis (likely course of the disease)
• Guide treatment decisions — Some genetic changes respond better to specific therapies
• Monitor for complications — Checking organ function before starting treatment

---

Questions to Ask YOUR Oncology Team

1. "Which of these tests have I already had completed?"

2. "Are there additional tests you recommend before we finalize my treatment plan?"

3. "What subtype of DLBCL do I have (GCB or non-GCB), and what does this mean for my treatment?"

4. "Do my biomarker results show any specific mutations that might guide treatment options?"

5. "What is my IPI score, and what does it tell us about my prognosis?"

6. "Will I need a bone marrow biopsy or lumbar puncture?"

7. "How will you use these test results to decide on my specific treatment plan?"

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.